chr9-113331073-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001012361.4(WDR31):āc.160T>Cā(p.Phe54Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000287 in 1,603,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001012361.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WDR31 | NM_001012361.4 | c.160T>C | p.Phe54Leu | missense_variant | 4/11 | ENST00000374193.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WDR31 | ENST00000374193.9 | c.160T>C | p.Phe54Leu | missense_variant | 4/11 | 1 | NM_001012361.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000529 AC: 8AN: 151340Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251062Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135688
GnomAD4 exome AF: 0.0000262 AC: 38AN: 1452334Hom.: 0 Cov.: 31 AF XY: 0.0000194 AC XY: 14AN XY: 722466
GnomAD4 genome AF: 0.0000529 AC: 8AN: 151340Hom.: 0 Cov.: 31 AF XY: 0.0000406 AC XY: 3AN XY: 73904
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 02, 2024 | The c.160T>C (p.F54L) alteration is located in exon 4 (coding exon 2) of the WDR31 gene. This alteration results from a T to C substitution at nucleotide position 160, causing the phenylalanine (F) at amino acid position 54 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at